Marcel Theodorus Den Hartog

Title: Marcel Theodorus Den Hartog: Innovator in Monoclonal Antibodies

Introduction

Marcel Theodorus Den Hartog is a notable inventor based in Monnickendam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is characterized by a focus on innovative solutions that address critical medical challenges.

Latest Patents

Den Hartog holds a patent for an antagonistic anti-human CD40 monoclonal antibody. This invention provides novel antagonistic anti-human CD40 monoclonal antibodies, methods for generating them, and various uses thereof. His patent represents a significant advancement in therapeutic options for diseases that involve the CD40 pathway.

Career Highlights

Den Hartog is associated with Fast Forward Pharmaceuticals B.V., a company dedicated to advancing pharmaceutical innovations. His role in the company has allowed him to contribute to groundbreaking research and development in the field of monoclonal antibodies.

Collaborations

Throughout his career, Den Hartog has collaborated with esteemed colleagues, including Ruprecht Jules Joost Van Neerven and Kevin Stuart Johnson. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Marcel Theodorus Den Hartog is a prominent figure in the biotechnology sector, with a focus on monoclonal antibodies. His contributions through patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future innovations in the field.